Clinical Trial Update: Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function [NA]

View source ↗

Summary

Clinical trial update shows the percutaneous left ventricular reshaping study for functional mitral regurgitation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Mitral Regurgitation

Snippet

Sponsor: Ancora Heart, Inc. | Conditions: Functional Mitral Regurgitation | NA | Status: COMPLETED